BioSpace News Archive

According to QY Research Medical, the Molecular Diagnostics Market size is projected to reach $23.9 billion by 2030 and growing at a registered CAGR of 9.86% from 2021 to 2030.

Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases announced that ANTICIPATE Study will be presented at the 2022 American Society of Clinical Oncology (ASCO) annual meeting (3-7 June) in Chicago.

According to Vision Research Reports, the cochlear implant market size is projected to hit around US$ 13.4 billion by 2030 from valued at US$ 8.70 billion in 2020, growing at a CAGR of 15.8% during the forecast period 2021 to 2030.

The report consists of quantitative and qualitative research on the market performed by our market experts.

Biologics Market was valued at USD 324.78 Billion in 2020 and is expected to reach a value of USD 749.62 Billion by 2028, and register a CAGR of 10.80% during the forecast period.

Humic Acid Market size was USD 707.5 million in 2020 and is expected to register a steady revenue CAGR of 5.9% during the forecast period.

Orthobiologics Market size was USD 5.58 Billion in 2020 and is expected to register a CAGR of 5.1% during the forecast period.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced it would present research on promising treatments for bladder and blood cancers, as well as studies on precision medicine and an experimental cancer vaccine, at the 2022 American Society of Clinical Oncology’s annual conference from June 3 to 7 in Chicago.

Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company.

Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula on U.S. store shelves in the coming weeks and months.